VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 132 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $562,000 | -49.8% | 42,297 | -13.3% | 0.03% | -45.1% |
| Q3 2018 | $1,120,000 | +107.0% | 48,810 | +71.8% | 0.05% | +131.8% |
| Q2 2018 | $541,000 | -46.0% | 28,410 | -52.3% | 0.02% | -45.0% |
| Q1 2018 | $1,002,000 | -6.5% | 59,510 | -0.7% | 0.04% | -27.3% |
| Q3 2017 | $1,072,000 | +131.0% | 59,900 | +110.2% | 0.06% | +120.0% |
| Q2 2017 | $464,000 | -58.0% | 28,500 | -63.9% | 0.02% | -51.0% |
| Q1 2017 | $1,106,000 | +44.2% | 79,000 | +64.2% | 0.05% | +10.9% |
| Q4 2016 | $767,000 | +216.9% | 48,100 | +229.5% | 0.05% | -41.0% |
| Q3 2016 | $242,000 | -24.1% | 14,600 | -57.5% | 0.08% | +420.0% |
| Q4 2015 | $319,000 | -20.8% | 34,352 | -20.9% | 0.02% | +7.1% |
| Q1 2015 | $403,000 | +112.1% | 43,406 | +226.4% | 0.01% | +100.0% |
| Q4 2014 | $190,000 | -86.9% | 13,299 | -90.0% | 0.01% | -91.1% |
| Q3 2013 | $1,452,000 | +74.9% | 132,693 | +29.1% | 0.08% | +192.6% |
| Q2 2013 | $830,000 | – | 102,767 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,532,000 | $27,423,000 | 3.23% |
| Stonepine Capital Management, LLC | 300,000 | $5,370,000 | 3.16% |
| Palo Alto Investors LP | 4,155,670 | $74,386,000 | 3.13% |
| GREAT POINT PARTNERS LLC | 497,531 | $8,906,000 | 1.73% |
| Avoro Capital Advisors LLC | 988,270 | $17,690,000 | 1.37% |
| UNIVERSITY OF NOTRE DAME DU LAC | 157,781 | $2,824,000 | 0.79% |
| Birchview Capital, LP | 68,000 | $1,217,000 | 0.63% |
| Cheyne Capital Management (UK) LLP | 74,000 | $1,323,000 | 0.48% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 352,604 | $6,311,000 | 0.43% |
| 361 CAPITAL LLC | 119,554 | $2,140,000 | 0.41% |